Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Non-alcoholic fatty liver disease is not a causal risk factor for psoriasis: A Mendelian randomization study of 108,835 individuals

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Differentially Expressed miRNAs in Ulcerative Colitis and Crohn's Disease

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  2. Extracellular Vesicle Therapy for Type 1 Diabetes

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  3. Antibody response following the third and fourth SARS-CoV-2 vaccine dose in individuals with common variable immunodeficiency

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Can patient-reported outcome measures be used to predict consultation needs in patients with psoriasis? A survey study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Common variants in breast cancer risk loci predispose to distinct tumor subtypes

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Gene–gene interaction of AhRwith and within the Wntcascade affects susceptibility to lung cancer

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. I am hiQ—a novel pair of accuracy indices for imputed genotypes

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Instruments assessing risk of bias of randomized trials frequently included items that are not addressing risk of bias issues

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Background: Psoriasis is observationally associated with a higher risk of non-alcoholic fatty liver disease (NAFLD); however, the causal relationship between the two diseases remains unclear.

Objective: We hypothesized that individuals with NAFLD or elevated liver fat content have higher risk of psoriasis and that NAFLD is a causal risk factor for psoriasis. We tested this using a Mendelian randomization approach.

Methods: We included 108,835 individuals from the Danish general population, including 1,277 individuals with psoriasis and 802 individuals with NAFLD according to ICD codes. To estimate liver fat content, a subset of the participants (N = 7,416) also had a CT scan performed. First, we tested whether a diagnosis of NAFLD or elevated liver fat content was observationally associated with risk of psoriasis. Subsequently, we used the genetic variants <i>PNPLA3</i> and <i>TM6SF2</i>, both strongly associated with NAFLD and high liver fat content, to test whether NAFLD was causally associated with increased risk of psoriasis.

Results: Observationally, individuals with vs. without a diagnosis of NAFLD had higher risk of psoriasis with an odds ratio of 2.03 (95% confidence interval 1.28-3.21). The risk of psoriasis increased in a stepwise manner with increasing liver fat content with an odds ratio of 5.00 (2.63-9.46) in individuals in the highest quartile of liver fat content compared to individuals in the lowest quartile. In genetic analyses, <i>PNPLA3</i> and <i>TM6SF2</i> were both associated with increased risk of NAFLD but not with increased risk of psoriasis.

Conclusion: Observationally, a diagnosis of NAFLD or elevated liver fat content was associated with higher risk of psoriasis. However, using genetic variants as a proxy for NAFLD, we did not find evidence of a causal relationship between NAFLD and psoriasis. Thus, the observational association between NAFLD and psoriasis is presumably a result of shared confounding factors or reverse causation.

OriginalsprogEngelsk
TidsskriftFrontiers in Immunology
Vol/bind13
Sider (fra-til)1022460
ISSN1664-3224
DOI
StatusUdgivet - 10 dec. 2022

Bibliografisk note

Copyright © 2022 Näslund-Koch, Bojesen, Gluud, Skov and Vedel-Krogh.

ID: 85728341